Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Carlyle (CG) EBT (2016 - 2026)

Carlyle has reported EBT over the past 15 years, most recently at $461.8 million for Q4 2025.

  • For Q4 2025, EBT rose 74.0% year-over-year to $461.8 million; the TTM value through Dec 2025 reached $1.2 billion, down 16.83%, while the annual FY2025 figure was $1.2 billion, 16.83% down from the prior year.
  • EBT for Q4 2025 was $461.8 million at Carlyle, up from $85.8 million in the prior quarter.
  • Over five years, EBT peaked at $1.3 billion in Q2 2021 and troughed at -$842.7 million in Q4 2023.
  • A 5-year average of $377.6 million and a median of $282.6 million in 2022 define the central range for EBT.
  • Biggest five-year swings in EBT: crashed 591.37% in 2023 and later skyrocketed 418.27% in 2024.
  • Year by year, EBT stood at $909.2 million in 2021, then plummeted by 81.14% to $171.5 million in 2022, then crashed by 591.37% to -$842.7 million in 2023, then skyrocketed by 131.49% to $265.4 million in 2024, then skyrocketed by 74.0% to $461.8 million in 2025.
  • Business Quant data shows EBT for CG at $461.8 million in Q4 2025, $85.8 million in Q3 2025, and $440.6 million in Q2 2025.